Dividends Calendar Earnings Calendar

LYEL | Lyell Immunopharma

  • Industry: Biotechnology

Quick infos

  • Headquarters:   South San Francisco, California, United States

Trade prices

  • Volume:
  • Market Cap: 3.57B
  • Prev closed:
  • Open: 12.84
  • High: 14.35
  • Low: 12.35
  • 52 week low: 10.62
  • 52 week high: 19.84
  • Dividends:No Dividends

Next ER: November 11, 2021 



Top Stories (LYEL)

    Company Profile

    Lyell is a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors. We focus on addressing what we believe are the primary barriers that limit consistent, reliable, and curative responses with adoptive T cell therapy: T cell exhaustion and loss of durable stemness, which includes proliferative capacity, ability to self-renew and ability to differentiate and eliminate solid tumors. We apply our proprietary ex vivo genetic and epigenetic reprogramming technology platforms, Gen-R and Epi-R, to address these barriers in order to develop new medicines with improved, durable, and potentially curative clinical outcomes.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    March 2, 2022
    December 1, 2021- / -0.5183- / 2.51M
    August 18, 2021-1.47 / -0.3752.63M / 2.31MBeat!
    June 9, 2021-0.12 / -1.26M / -Beat!
    June 2, 2021-2.45 / -2.45M / -Beat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Nov 11, 2021 11.52 11.97
    11.97
    11.22
    244.24K -4.4%
    Nov 10, 2021 12.05 12.05
    12.31
    11.75
    330.36K 0.33%
    Nov 9, 2021 12.01 12.93
    12.93
    11.62
    265.19K -7.33%
    Nov 8, 2021 12.96 13.70
    14.15
    12.71
    274.42K -6.22%
    Nov 5, 2021 13.82 14.98
    15.02
    13.55
    108.62K -7.43%
    Nov 4, 2021 14.93 14.05
    15.41
    13.94
    234.78K 6.72%
    Nov 3, 2021 13.99 14.86
    15.49
    13.71
    472.78K -5.73%
    Nov 2, 2021 14.84 14.12
    15.28
    13.84
    144.37K 4.95%
    Nov 1, 2021 14.14 14.01
    14.38
    13.54
    260.63K 1.43%
    Oct 29, 2021 13.94 14.74
    15.32
    13.57
    293.41K -4.98%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2018
    • Employees:188

    News

    News for (LYEL)

    This company doesn't provide a dividend.


    Talk about Lyell Immunopharma below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 11, 2021 (Same day)

    jobs.ch sbh crbp dds epc flo wix tpr codx pags sbs pdd 


    Jump to (Finance sites)

    Their Official Profiles 

    LinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Investing For Dummies
    Buy on Amazon

    In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.